Carl Evans's most recent trade in Highwoods Properties, Inc. was a trade of 3,060 Common Stock done . Disclosure was reported to the exchange on May 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Highwoods Properties, Inc. | Carlos E. Evans | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 3,060 | 69,333 (0%) | 0% | 0 | Common Stock | |
| Cns Pharmaceuticals Inc | Carl Evans | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2024 | 17,500 | 147,094 | - | - | Restricted Stock Units | |
| Cns Pharmaceuticals Inc | Carl Evans | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2024 | 17,500 | 129,594 | - | - | Option to purchase common stock | |
| Highwoods Properties, Inc. | Carlos E. Evans | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 3,786 | 66,273 (0%) | 0% | 0 | Common Stock | |
| Highwoods Properties, Inc. | Carlos E. Evans | Director | Purchase of securities on an exchange or from another person at price $ 23.67 per share. | 22 Feb 2024 | 20,000 | 62,487 (0%) | 0% | 23.7 | 473,400 | Common Stock |
| Cns Pharmaceuticals Inc | Carl Evans | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 33,333 | 78,761 | - | - | Series A Warrant to purchase common stock | |
| Cns Pharmaceuticals Inc | Carl Evans | Director | Purchase of securities on an exchange or from another person at price $ 0.30 per share. | 01 Feb 2024 | 33,333 | 33,458 (0%) | 0% | 0.3 | 10,000 | Common stock |
| Cns Pharmaceuticals Inc | Evans Carl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 33,333 | 112,094 | - | - | Series B Warrant to purchase common stock | |
| Highwoods Properties, Inc. | Carlos E. Evans | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 3,211 | 42,487 (0%) | 0% | 0 | Common Stock | |
| Cns Pharmaceuticals Inc | Carl Evans | Director | Grant, award, or other acquisition of securities at price $ 0.27 per share. | 08 Mar 2022 | 3,750 | 3,750 (0%) | 0% | 0.3 | 1,005 | Common Stock |
| Highwoods Properties, Inc. | Carlos E. Evans | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 2,085 | 39,276 (0%) | 0% | 0 | Common Stock | |
| Cns Pharmaceuticals Inc | Carl Evans | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 32,000 | 178,559 | - | - | Option to purchase common stock | |
| Highwoods Properties, Inc. | Carlos E. Evans | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 2,215 | 37,191 (0%) | 0% | 0 | Common Stock | |
| Highwoods Properties, Inc. | Carlos E. Evans | Director | Purchase of securities on an exchange or from another person at price $ 33.70 per share. | 22 Sep 2020 | 10,000 | 34,976 (0%) | 0% | 33.7 | 337,000 | Common Stock |